Ascendis Pharma A/S (ASND)
133.62
+0.49
(+0.37%)
USD |
NASDAQ |
May 10, 16:00
133.62
0.00 (0.00%)
After-Hours: 20:00
Ascendis Pharma Revenue (TTM): 356.43M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 356.43M |
| December 31, 2023 | 288.35M |
| September 30, 2023 | 163.47M |
| June 30, 2023 | 126.57M |
| March 31, 2023 | 81.45M |
| December 31, 2022 | 53.04M |
| September 30, 2022 | 35.23M |
| June 30, 2022 | 21.14M |
| March 31, 2022 | 15.81M |
| December 31, 2021 | 9.044M |
| September 30, 2021 | 4.081M |
| June 30, 2021 | 5.993M |
| March 31, 2021 | 6.342M |
| December 31, 2020 | 7.899M |
| September 30, 2020 | 10.04M |
| June 30, 2020 | 9.307M |
| March 31, 2020 | 11.33M |
| December 31, 2019 | 15.03M |
| September 30, 2019 | 24.25M |
| June 30, 2019 | 21.78M |
| Date | Value |
|---|---|
| March 31, 2019 | 18.19M |
| December 31, 2018 | 12.08M |
| September 30, 2018 | 0.4089M |
| June 30, 2018 | 0.8958M |
| March 31, 2018 | 1.363M |
| December 31, 2017 | 1.725M |
| September 30, 2017 | 2.520M |
| June 30, 2017 | 3.315M |
| March 31, 2017 | 4.110M |
| December 31, 2016 | 5.101M |
| September 30, 2016 | 6.139M |
| June 30, 2016 | 7.187M |
| March 31, 2016 | 8.051M |
| December 31, 2015 | 9.011M |
| September 30, 2015 | 10.38M |
| June 30, 2015 | 12.33M |
| March 31, 2015 | 15.55M |
| December 31, 2014 | 18.68M |
| September 30, 2014 | 22.71M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.081M
Minimum
Sep 2021
356.43M
Maximum
Mar 2024
63.33M
Average
18.47M
Median